Medical Prota Therapeutics US $21 Million Financing Led by SPRIM Global InvestmentsBy Marie JonesJanuary 16, 2024 Financing advances development of Prota’s peanut allergy remission therapy in preparation for a Phase 3 clinical trial Prota Therapeutics Pty Ltd…
